Stonepine Capital Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001440771

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q4 2023 · 16 positions · Total reported value $231.23M · Top-10 concentration 95.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 72.7% · 16 new · 27 cut · 29 exited

Active Share (vs S&P 500): 99.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -2.9% · vs SPY -5.0% · Prev Value $151.28M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -4.9% · vs SPY -7.1% · Latest Value $130.24M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2023 13F filing, Stonepine Capital Management, LLC disclosed 16 equity positions with a combined reported value of $231.23M. The filing implies a focused portfolio: its ten largest positions account for 95.3% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2023 were EOLS ($56.16M), ADMA ($41.69M), AMLX ($36.80M). By sector, the heaviest allocations are Health Care 84.6%, Other 15.4%. Versus the prior quarter, allocation shifted toward Health Care (+4.4pp) and away from Other (-4.4pp).

Versus the prior quarter, Stonepine Capital Management, LLC opened 16 new positions, trimmed 27 and fully exited 29, a turnover rate of 72.7% of positions. The portfolio's overlap with the prior quarter was 70% of names.

Of the 29 positions fully exited versus the prior quarter, the largest were MXCT ($11.74M), GMDAQ ($8.20M), XFOR ($5.75M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2023)

No new positions this quarter.

Fully Exited (vs previous quarter)

  • MXCT MAXCYTE INC · prev qtr: $11.74M
  • GMDAQ GAMIDA CELL LTD · prev qtr: $8.20M
  • XFOR X4 PHARMACEUTICALS INC · prev qtr: $5.75M
  • GOSS GOSSAMER BIO INC · prev qtr: $2.78M · history
  • DCTH DELCATH SYS INC · prev qtr: $2.78M
  • ASRT ASSERTIO HOLDINGS INC · prev qtr: $2.44M
  • VNDA VANDA PHARMACEUTICALS INC · prev qtr: $2.06M

Insider Transactions (Form 4)

Latest Stonepine Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Stonepine Capital Management, LLC is an SEC-registered 13F filer based in Bend, OR, United States. As of Q2 2026 it reported 83 US equity positions with a combined value of $151.28M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: BEND, OR, United States
  • SEC registration: 801-136874 (status: Approved), registered 2026-07-22
  • Regulatory AUM (Form ADV): $181.00M as of 2026-06-26
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: stonepinecap.com

Portfolio Structure

  • 83 positions · $151.28M reported value (Q2 2026)
  • Top 10 holdings = 44.6% of reported value
  • Largest position: VSTM (VERASTEM INC) at 8.5%
  • Average position size: $1.82M

Sector Tilt

  • Health Care 99.8%
  • Industrials 0.2%
  • Materials 0.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 23 new, 28 added, 24 reduced, 12 exited
  • 8 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 84.6%
Other 15.4%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 5.33M $56.16M 24.29%
24.29%
Add
2 9.22M $41.69M 18.03%
18.03%
Add
3 2.50M $36.80M 15.91%
15.91%
Reduce
4 450.00K $33.16M 14.34%
14.34%
Reduce
5 4.00M $17.28M 7.47%
7.47%
Hold
6 5.94M $13.95M 6.03%
6.03%
Hold
7 261.87K $10.65M 4.60%
4.60%
Reduce
8 250.00K $4.62M 2.00%
2.00%
Reduce
9 1.67M $3.13M 1.35%
1.35%
Reduce
10 1.36M $3.02M 1.31%
1.31%
Reduce
11 2.77M $2.75M 1.19%
1.19%
Reduce
12 839.51K $2.56M 1.11%
1.11%
Reduce
13 317.78K $2.10M 0.91%
0.91%
Reduce
14 472.47K $1.34M 0.58%
0.58%
Hold
15 669.68K $1.33M 0.58%
0.58%
Reduce
16 482.26K $679.98K 0.29%
0.29%
Reduce

FAQ

What did Stonepine Capital Management, LLC buy in 2023-Q4?

In its 2023-Q4 13F filing, Stonepine Capital Management, LLC reported 16 equity positions worth $231.23M in aggregate; its largest disclosed positions were EOLS ($56.16M), ADMA ($41.69M), AMLX ($36.80M).

How large is Stonepine Capital Management, LLC's portfolio?

Stonepine Capital Management, LLC reported $231.23M of long equity holdings across 16 positions as of 2023-Q4. Top-10 holdings account for 95.3% of reported value.

What is Stonepine Capital Management, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/stonepine-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →